CTC
QNTM

Cetera Trust Company’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Cetera Trust Company’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.21K Hold
250
– – ﹤0.01% 349
2025
Q4 		$1.82K Hold
250
– – ﹤0.01% 356
2025
Q3 		$4.1K Hold
250
– – ﹤0.01% 344
2025
Q2 		$5.06K Hold
250
– – ﹤0.01% 342
2025
Q1 		$1.93K Buy
+250
New +$1.44K ﹤0.01% 370

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Cetera Trust Company's QNTM Position: Q1 2026 in Review

Cetera Trust Company held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q1 2026 at 250 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #349.

Cetera Trust Company first reported a position in QNTM in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.06K in Q2 2025. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

  • Cetera Trust Company held 250 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $1.21K as of Q1 2026.
  • Cetera Trust Company left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q1 2026.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Cetera Trust Company's portfolio in Q1 2026, its #349 holding.
  • Cetera Trust Company first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2025 and has held it in 5 quarters since.
  • Cetera Trust Company's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $5.06K in Q2 2025.
  • 25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.